Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Specific RNase isoenzymes in the human central nervous system.

B Allinquant¹, C Musenger, J Reboul

¹Laboratoire de Neuro-Immunologie, INSERM U 134, Hôpital de la Salpêtrière, Paris, France.

Neurochemical Research

|December 1, 1987

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The free plasma amyloid Aβ<sub>1</sub><sub>-</sub><sub>42</sub>/Aβ<sub>1</sub><sub>-</sub><sub>40</sub> ratio predicts conversion to dementia for subjects with mild cognitive impairment with performance equivalent to that of the total plasma Aβ<sub>1</sub><sub>-</sub><sub>42</sub>/Aβ<sub>1</sub><sub>-</sub><sub>40</sub> ratio. The BALTAZAR study.

Neurobiology of disease·2024

Same author

Follicular flushing versus direct aspiration in poor responder IVF patients: a randomized prospective study.

European journal of obstetrics, gynecology, and reproductive biology·2020

Same author

Frequency and relevance of IgM intrathecal synthesis in multiple sclerosis.

European journal of neurology·2013

Same author

Immunogenicity and safety of IXIARO (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age.

Vaccine·2009

Same author

Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study.

Vaccine·2009

Same author

Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study.

Vaccine·2008

Two specific human cerebrospinal fluid (CSF) ribonuclease (RNase) isoenzymes, RNase 3.1 and RNase 3.2, are found in the central nervous system (CNS) and may indicate RNA breakdown in brain cells.

Area of Science:

Neuroscience
Biochemistry
Molecular Biology

Background:

Alkaline ribonuclease (RNase) activity is present in human brain tissue, with higher levels observed in white matter compared to grey matter.
RNase isoenzymes are crucial for RNA metabolism and their dysregulation can be implicated in neurological disorders.

Purpose of the Study:

To investigate the presence and specificity of RNase isoenzymes in human brain tissue and cerebrospinal fluid (CSF).
To determine if specific RNase isoenzymes can serve as biomarkers for central nervous system (CNS) conditions.

Main Methods:

Extraction and analysis of alkaline RNase activity from human brain tissue (grey matter, white matter, purified myelin), CSF, serum, and other organs.
Characterization of RNase isoenzymes, including their presence, relative abundance, and potential glycosylation differences.

Related Experiment Videos

Comparison of RNase profiles between human and animal models, as well as between healthy and pathological human CSF samples.

Main Results:

Two group 3 RNase isoenzymes, RNase 3.1 (minor) and RNase 3.2 (major), were identified in human brain extracts and CSF but not in peripheral tissues or serum.
These RNases (3.1 and 3.2) were specific to human CNS and absent in mouse, rat, and bovine brains.
The ratio of RNase 3.1-3.2 to another group 3 RNase (RNase 3.0) was altered in pathological CSF, particularly in conditions like multiple sclerosis and infectious CNS diseases.

Conclusions:

RNase isoenzymes 3.1 and 3.2 are specific to the human central nervous system and likely originate from brain tissue.
These human-specific CNS RNases may serve as potential biomarkers for RNA catabolism within brain cells and could be indicative of neurological disease states.